Intrarenal angiotensin converting enzyme inhibition in spontaneously hypertensive rats

By Aihara H.   Ogawa H.   Kasuya A.   Yoshida M.   Suzuki-Kusaba M.   Hisa H.   Satoh S.  

European Journal of Pharmacology, Vol. 373, Iss. 1, 1999-05 ,pp. : 35-40

Elsevier

Access to resources Recommend Favorite

Effects of long-acting angiotensin-converting enzyme inhibitor, imidapril, on the lower limit of cerebral blood flow autoregulation in hypertensive rats

By Cai H.   Yao H.   Ibayashi S.   Zhao G.   Kitazono T.   Nagao T.   Fujishima M.  

European Journal of Pharmacology, Vol. 341, Iss. 1, 1998-01 ,pp. : 73-77

Elsevier

Access to resources Recommend Favorite

Angiotensin‐converting enzyme inhibition prevents myocardial infarction‐induced increase in renal cortical cGMP and cAMP phosphodiesterase activities

By  

Fundamental & Clinical Pharmacology, Vol. 29, Iss. 4, 2015-08 ,pp. : 352-361

John Wiley & Sons Inc

Access to resources Recommend Favorite

Blockade of angiotensin converting enzyme but not of angiotensin AT 1 receptors improves glucose tolerance

By Chow L.   De Gasparo M.   Levens N.  

European Journal of Pharmacology, Vol. 319, Iss. 1, 1997-01 ,pp. : 77-83

Elsevier

Access to resources Recommend Favorite

Effects of angiotensin II and angiotensin-converting enzyme inhibitors on human myocardium

By Lenz O.   Schmid B.   Kilter H.   La Rosee K.   Flesch M.   Kuhn-Regnier F.   Sudkamp M.   Bohm M.  

European Journal of Pharmacology, Vol. 294, Iss. 1, 1995-01 ,pp. : 17-27

Elsevier

Access to resources Recommend Favorite